AzTrials
AzTrials

StrokeNCT06187467

Longitudinal Multimodal Profiling of Balance and Gait In Stroke

An observational study of Stroke, run by Tan Tock Seng Hospital at 1 site in Singapore.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Balance and gait recovery is a critical aspect of post-stroke motor rehabilitation. Researchers have effectively utilized EEG to investigate different aspects of lower limb motor control, however there are several technical challenges in the existing brain computer interface (BCI) motor profiling. Read more about this study

Who is it for?
Ages 21 to 85 years
Conditions the study is for
Stroke
What is being tested?
Clinical and technological-aided assessments and questionnaires
How many people
16 participants
Where
1 siteSingapore
Study dates
1 Jul 2024to 20 Jun 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients in outpatient clinics

Who may be able to join

  • First-ever clinical stroke (ischaemic or haemorrhagic) confirmed by admitting doctors brain imaging
  • Age 21 to 85 years
  • At least ≥ 30 days post-stroke
  • Gait impairments related to stroke
  • Functional ambulation category -6 levels (Mehrholz et al, 2007): FAC ≥ 4, i.e. able to ambulate independently on level surface but requires supervision to negotiate (e.g. stairs, inclines, non-level surfaces).
  • Montreal Cognitive Assessment (MoCA) score > 21 (Nasreddine et al., 2005)
  • Able to understand study instructions and requirements

Who cannot join

  • Non-stroke related causes of gait impairment
  • Medical conditions incompatible with research participation: uncontrolled medical illnesses (hypertension or diabetes, ischaemic heart disease, congestive heart failure, bronchial asthma, severe /untreated depression, agitation, end stage renal/liver/heart/lung failure, dialysis, unresolved cancers e.g.,), active seizures within 3 months
  • Anticipated life expectancy of < 6 months
  • On subcutaneous or oral anti-coagulation
  • Local factors potentially worsened by gait training: joint and muscle pains
  • Lower limb pain VAS >4/10, active lower limb fractures or arthritis, fixed leg contractures, severe peripheral vascular disease, organomegaly or aortic aneurysms
Show all 12Show fewer
  • Active unhealed skin wounds or inflammatory skin conditions over trunk and lower limbs,
  • Severe visual impairment or visual neglect affecting navigation
  • Known allergy to EEG gel (Recoverix)
  • Presence of craniectomy skull defect
  • Resident of nursing home or overseas country which may compromise attendance at research site
  • Pregnant or lactating females

Trial locations and contacts

1 site in 1 country.

Singapore1 site
  • Tan Tock Seng Hospital

    Singapore, Singapore

Other trials in Singapore

About this study

Official title: Longitudinal Multimodal Profiling of Balance and Gait In Stroke Using EEG and Lower Limb Sensors: A Feasibility Study.

Balance and gait recovery is a critical aspect of post-stroke motor rehabilitation. Researchers have effectively utilized EEG to investigate different aspects of lower limb motor control, however there are several technical challenges in the existing brain computer interface (BCI) motor profiling.

The study aims to test the EEG-BCI system to see if it's effective in understanding the balance and walking patterns of post-stroke populations.

Read the detailed description

Brain Computer Interface represent a groundbreaking field at the crossroads of neuroscience and engineering, serving as a direct communication link between the human brain and computer system.

Despite advancements in BCI technology, the electrocortical oscillations during human walking remain relatively unexplored, providing an opportunity for pioneering investigations.

The research highlights the feasibility of using EEG to decode neural patterns associated with various functions and aims to contribute to existing knowledge by using advanced EEG-based techniques to predict balance and gait patterns with the ultimate goal of tailoring rehabilitation approaches to individual patient needs.

Conditions
Stroke
Being tested
Clinical and technological-aided assessments and questionnaires
Keywords
Electroencephalographic (EEG), Brain Computer Interfaces
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Clinical and technological-aided assessments and questionnairesOther

    Assessments and questionnaires to quantify cortical and motor activities using portable EEG and lower limb sensors during dynamic balance and gait activities.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. EEG Activities

    To record EEG and EOG data from 64-Ch ActiCap EEG cap and electrode

    Measured: Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

  2. Goniometers

    7 sensors to measure 2-axis joint angles at bilateral Hip, Knee and Ankle

    Measured: Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

Secondary outcomes (5)
  1. Fugl Meyer Assessment for Lower Limbs

    Change in Fugl Meyer Motor Assessment score in the affected arm, minimum: 0, maximum: 66 with higher scores indicating greater levels of mobility function

    Measured: Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

  2. Berg Balance Scale

    To assess functional balance

    Measured: Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

  3. Modified Clinical Test for Sensory Interaction in Balance

    Assess complex sensory system to assist in determining which sensory system the individual relies upon (visual, somatosensory, vestibul)

    Measured: Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

  4. 10-metre Walk Test

    To assess walking speed over a short distance

    Measured: Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

  5. 6-minute Walk Test

    Determine the functional exercise capacity

    Measured: Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jan 2024
  2. Study start1 Jul 2024
  3. Primary completion20 Jun 2025
  4. Study completion20 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06187467
Sponsor's protocol ID
DSRB 2023/00805
Status last verified
Jun 2026
First submitted
4 Dec 2023
Last updated
7 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke, run by Tan Tock Seng Hospital at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

EEG Activities (time frame: Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in